Association of Long-Term Use of Proton Pump Inhibitors and Histamine-2 Receptor Antagonists with Vitamin B12 Deficiency

Authors

  • Aarfa Jamal Post graduate resident, General medicine, Abbasi Shaheed hospital
  • Aneela Altaf Kidwai Professor of medicine, General medicine, Abbasi Shaheed hospital
  • Syeda Amna Gouhar Postgraduate trainee, General medicine, Abbasi Shaheed Hospital
  • Meah para Lodhi General medicine, Abbasi Shaheed hospital

DOI:

https://doi.org/10.65433/mjms.v4i2.235

Abstract

Objective: To determine the association of long-term proton pump inhibitor, use and histamine 2 receptor antagonist with vitamin B12 deficiency.

Methodology: This Case-control Study was executed at the Department of General Medicine, Abbasi Shaheed Hospital, Karachi, from 15th March 2025 to 14th September 2025. The study included adult’s participants of both genders, aged between 20 to 70 years. The sample size of 100 vitamin B12-deficient cases and 100 controls were included through non-probability consecutive sampling. Long-term proton pump inhibitor or histamine-2 receptor antagonist use (≥ 2 years) served as the exposure. Data were analysed in SPSS 26 with Chi-square analyses and odds ratios, with p-value was taken to be below 5% as significant.

Results: The mean age of vitamin B₁₂-deficient patients was 61.6 ± 9.4 years, and 56% were females. Mean serum vitamin B₁₂ levels were significantly lower in deficient patients (148.9 ± 29.6 pg/ml) compared to controls (466.5 ± 129.2 pg/ml; p < 0.001). Long-term PPI use showed an adjusted odds ratio (OR) of 2.156 (95% CI: 0.826–5.626; p = 0.116), while H₂RA use had an adjusted OR of 1.264 (95% CI: 0.319–5.015; p = 0.739). Diabetes mellitus was significantly associated with vitamin B₁₂ deficiency (p = 0.038).

Conclusion: This investigation revealed an absence of statistically significant association between prolonged administration of PPI or H2Ras and the incidence of vitamin B₁₂ deficiency within the cohort of assessed patients. Diabetes mellitus, however, was identified as an independent predictor of low vitamin B₁₂ levels. These findings emphasize careful and rational use of acid-suppressive medications and highlight the need for periodic vitamin B₁₂ monitoring in diabetic and vitamin B₁₂-deficient patients receiving prolonged acid suppression. This null finding is inconclusive rather than confirmation of safety, given the limited sample size and single time-point measurement.

Downloads

Published

2026-06-12

Issue

Section

Original Articles